PatternsRadar
Sign in

NOVARTINDNovartis India Limited

NSE
Full chart
2,051.20INR+83.40 (+4.24%)Close · 6 Oct 2026
—Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹5,065 CrMarket cap
—P/E (TTM)
39.2%Delivery

Filings & corporate actions

CSV
Dividend
₹47.50 per share · last 20 Jul 2023
2023
  • 20 JuldividendDividend · ₹47.50 per share

Growth

CSV
Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open1,971.00
Day range1,936.80 – 2,076.20
52-week range—
From 52w high—
RSI (14)59.9
ATR (14)130.03
Volume51.0K
Avg volume (20D)2.61L
Rel volume0.20×
Volatility (1Y)61.5%
Turnover₹10.5Cr
SMA 50 / 2001,750.21 / —

Delivery percentage

Latest · 6 Oct 202639.2%
20-day avg32.9%
1-year avg54.1%
Percentile (own history)15th
Range12.0–89.4%
Sessions117

Over the last 20 sessions NOVARTIND settled 32.9% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 54.1%, so recent sessions are running 21.2 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Performance returns

CSV
1D1W1M3M6M1Y
Price+4.24%+6.01%+27.08%+40.71%——

Valuation

CSV
Market cap₹5,065 Cr
P/E (TTM)—
EPS (TTM)—
Shares outstanding—
Listed20 Apr 2026

Ownership

Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

NOVARTIND at a glance

  • NOVARTIND closed at ₹2,051.2 on 6 Oct 2026, +4.24% on the day.
  • Delivery was 39.2% of traded quantity on 6 Oct 2026, the 15th percentile of its own 117 sessions with a reading (20-session average 32.9%, 1-year average 54.1%).
  • Market capitalisation is ₹5,065 crore, with no positive trailing earnings for a P/E.